Circulating miRNA in patients with non-alcoholic fatty liver disease and coronary artery disease

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and coronary artery disease (CAD) is the cardiac manifestation of metabolic syndrome. NAFLD is strongly linked to CAD and hepatic steatosis is an independent risk factor for CAD and cardiac morta...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMJ Open Gastroenterol
Hauptverfasser: Mehta, Rohini, Otgonsuren, Munkzhul, Younoszai, Zahra, Allawi, Hussain, Raybuck, Bryan, Younossi, Zobair
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMJ Publishing Group 2016
Schlagworte:
Hepatology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4964159/
https://ncbi.nlm.nih.gov/pubmed/27493762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjgast-2016-000096
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge